bupropion and semaglutide What's New in Obesity Treatment? Obesity drugs under review: Semaglutide,

watch now India's weight-loss drug boom: Novo Nordisk talks about GLP-1 generics after patent expiry The patent on semaglutide, found in Novo Nordisk's Ozempic and Wegovy weight-loss drugs, expired in India on March 20

Drawn from five year clinical trial, it was established that Wegovy reduced MACE by 20 percent than placebo group

This precision approach delivers better results within evidence-based weekly dosing frameworks

Effects of dapagliflozin on mortality in patients with chronic kidney disease: A pre-specified analysis from the DAPA-CKD randomized controlled trial

He then talked about the three pillars of #DrugDiscovery, to which, in his view, #ArtificialIntelligence can make the biggest contributions at the moment: - understanding diseases - selecting the right targets - predicting suitable therapeutic modalities Next, he discussed the design of a Bcl-2 inhibitor that is highly selective over Bcl-xL